We seek original research, clinical trials, systematic reviews, translational studies, and methodological advances that connect mechanisms to patient outcomes.

Submissions are reviewed by an international editorial board with expertise in translational medicine, pharmacology, diagnostics, and clinical research. Open access ensures rapid and global dissemination.

We welcome multidisciplinary studies that bridge basic science with clinical practice, including biomarker validation, therapeutic development, and real world effectiveness studies.

Well designed studies with negative or null results are welcome when they provide clear methods and meaningful interpretation for the field.

• Manuscriptzone submission: https://oap.manuscriptzone.net/
• Simple Manuscript Submission: https://openaccesspub.org/manuscript-submission-form

Include a concise cover letter describing novelty, clinical relevance, and any special issue alignment. Submissions are accepted year round.

Suggested reviewer names can be included in submission notes to help the editorial office match expertise efficiently.

If your study is time sensitive, note this in the cover letter so we can advise on feasibility and scheduling.

Published articles are immediately accessible to clinicians, researchers, and industry partners, supporting rapid uptake into practice and policy.

Authors benefit from structured metadata, indexing readiness, and clear licensing that supports reuse in education and guideline development.

The journal encourages submissions that highlight clinical implications and provide data that can inform therapeutic development or patient care pathways.

• Original research and clinical trials
• Systematic reviews and meta analyses
• Translational studies linking mechanism to therapy
• Short communications and technical notes
• Case series with strong educational value

Submissions should include clear methodology, ethical compliance, and data availability statements when relevant.

Authors are encouraged to align manuscripts with reporting guidelines appropriate to the study design.

If your work aligns with a special issue theme, note this in the cover letter to ensure appropriate routing.

Guest editors collaborate with the journal office to coordinate peer review and timeline milestones.

Special issues follow the same peer review standards as regular submissions and maintain consistent editorial integrity.

Use a structured abstract and clear keywords that align with disease pathways, translational mechanisms, or clinical outcomes.

Provide complete data availability statements and disclose funding sources and conflicts of interest. These elements support transparency and compliance.

High quality figures and clear statistical reporting improve interpretation and reduce revision cycles.

If your manuscript includes clinical trial data, provide registration details and describe safety monitoring methods.

Editors assess scope fit, methodological rigor, and potential clinical impact before assigning reviewers. Clear reporting and transparent data statements support faster review.

Reviewers evaluate study design, statistical validity, and interpretation. Manuscripts that provide strong mechanistic insight or clinical relevance are prioritized for timely decisions.

If revisions are requested, authors should respond clearly and highlight changes to support efficient re evaluation.

Well organized submissions with clear tables and figures reduce the number of clarification requests during review.

Concise method descriptions and transparent reporting of limitations improve reviewer confidence and can shorten decision timelines.

Authors should ensure that conclusions align with the reported data to maintain credibility and support positive editorial outcomes.

Well structured submissions help reviewers focus on novelty and clinical relevance.